U.S. and China Trade War, and Why Experts Disagree on its Impact

 

The ongoing trade war between the United States and China continues to make an impact on businesses even beyond the two nations’ borders.

U.S. Trade Representative Robert Lighthizer and Treasury Secretary Steven Mnuchin are currently meeting with Chinese diplomats in Shanghai to find a resolution. Until an agreement is reached though, businesses and consumers will continue to deal with the uncertainty.

“I don’t think there’s much optimism, or I’m pretty sure there is no optimism, that this round of talks is going to get very far,” Southern Methodist University Associate Professor of Economics James Lake said.

The nations announced a deal was imminent just months ago, but both sides have tempered expectations since the breakdown of the last round of talks. With no resolution in plain view, Lake says businesses reliant on Chinese imports or exports can hunker down and wait for the results of the 2020 U.S. presidential election, or make a significant shift away from China to mitigate any further tariffs.

“Given the uncertainty about the trade war happening in China and also the Chinese market perhaps not being as attractive as it has in the recent past in terms of labor cost, now could be the time to potentially think about moving the supply chain out of China to somewhere else,” Lake said.

The solutions to this uncertainty in the meantime depends on individuals’ circumstances and businesses are approaching this differently, according to Phil Levy, Chief Economist at Flexport, a San Francisco-based digital freight forwarder.

“You see companies sort of able to shift in some cases to products which have not yet been hit by tariffs. You also see companies to some extent rework their supply chain to avoid these tariffs, which for the most part have applied to direct trade between China and the United States, so we see some preliminary evidence of both,” Levy said. “We also see that companies are simply paying a lot of money in tariffs.”

Only time will tell how the trade war comes to a ceasefire, but for businesses that need to make investments presently, their futures will be defined by their decisions today.

For the latest news, videos, and podcasts in the AEC Industry, be sure to subscribe to our industry publication.

Follow us on social media for the latest updates in B2B!

Twitter – @AECMKSL
Facebook – facebook.com/marketscale
LinkedIn – linkedin.com/company/marketscale

Follow us on social media for the latest updates in B2B!

Image

Latest

personal branding
Personal Branding Now Drives B2B Success, Customer Trust, and Competitive Advantage
December 5, 2025

Personal branding has rapidly shifted from a “nice-to-have” to a strategic imperative in B2B marketing, reshaping how companies communicate, differentiate, and build trust. As industries evolve and professionals take on more dynamic, multi-stream careers, visibility and authenticity have become critical assets. Key findings from the Edelman + LinkedIn Thought Leadership Impact Report show that…

Read More
IT
Real-World IT Practices Are Streamlining AV Deployments and Raising the Bar for Consistency
December 4, 2025

For years, the AV industry has discussed the long-anticipated convergence with IT—but that shift is no longer theoretical. With cloud adoption accelerating, hybrid work normalizing, and organizations rebuilding digital infrastructure after years of rapid change, AV systems now sit squarely on the IT backbone. In fact, the majority of newly upgraded conference rooms require network-centric…

Read More
ROI
ROI Case Study
December 3, 2025

Denials are no longer a slow leak in the revenue cycle—they’re a fast-moving, rule-shifting game controlled by payers, and hospitals that don’t model denial patterns in real time end up budgeting around losses they could have prevented. PayerWatch’s four-digit, client-verified ROI in 2024 shows what happens when a hospital stops reacting claim by…

Read More
coverage
Clip 2 – Fighting for Coverage: One Patient’s Story
December 3, 2025

Health insurers love to advertise themselves as guardians of care, but the real story often begins when a patient’s life no longer fits neatly into a spreadsheet. In oncology especially, “coverage” isn’t a bureaucratic checkbox—it’s the fragile bridge between a treatment that finally works and a relapse that can undo years of grit…

Read More